Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders

While the prevalence of metabolic syndrome (MetS) is steadily increasing worldwide, no optimal pharmacotherapy is readily available to address its multifaceted risk factors and halt its complications. This growing challenge mandates the development of other future curative directions. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldman, Francis, Koudoufio, Mireille, El-Jalbout, Ramy, Sauvé, Mathilde Foisy, Ahmarani, Lena, Sané, Alain Théophile, Ould-Chikh, Nour-El-Houda, N’Timbane, Thierry, Patey, Natalie, Desjardins, Yves, Stintzi, Alain, Spahis, Schohraya, Levy, Emile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854780/
https://www.ncbi.nlm.nih.gov/pubmed/36670951
http://dx.doi.org/10.3390/antiox12010090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854780/
https://www.ncbi.nlm.nih.gov/pubmed/36670951
http://dx.doi.org/10.3390/antiox12010090

Ejemplares similares